Endonovo Therapeutics, Inc. (ENDV)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Endonovo Therapeutics Debt to Equity Ratio : -0.2343 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2343 |
| March 31, 2026 | -0.2364 |
| December 31, 2025 | -0.2395 |
| September 30, 2025 | -0.2437 |
| June 30, 2025 | -0.2479 |
| March 31, 2025 | -0.252 |
| December 31, 2024 | -0.2563 |
| September 30, 2024 | -0.268 |
| June 30, 2024 | -0.2754 |
| March 31, 2024 | -0.2846 |
| December 31, 2023 | -0.2934 |
| September 30, 2023 | -0.3074 |
| June 30, 2023 | -0.3165 |
| March 31, 2023 | -0.2832 |
| December 31, 2022 | -0.2223 |
| September 30, 2022 | -0.3693 |
| June 30, 2022 | -0.384 |
| March 31, 2022 | -0.4044 |
| December 31, 2021 | -0.4553 |
| September 30, 2021 | -0.3717 |
| June 30, 2021 | -0.3921 |
| March 31, 2021 | -0.4218 |
| December 31, 2020 | -0.4616 |
| September 30, 2020 | -0.4781 |
| June 30, 2020 | -0.5095 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5548 |
| December 31, 2019 | -0.4232 |
| September 30, 2019 | -0.537 |
| June 30, 2019 | -0.5225 |
| March 31, 2019 | -0.6809 |
| December 31, 2018 | -0.6904 |
| September 30, 2018 | -0.5967 |
| June 30, 2018 | -0.7741 |
| March 31, 2018 | -0.7109 |
| December 31, 2017 | -0.5586 |
| September 30, 2017 | -0.207 |
| June 30, 2017 | -0.2604 |
| March 31, 2017 | -0.1536 |
| December 31, 2016 | -0.2412 |
| September 30, 2016 | -0.2228 |
| June 30, 2016 | -0.2267 |
| March 31, 2016 | -0.1741 |
| December 31, 2015 | -0.1685 |
| September 30, 2015 | -0.2568 |
| June 30, 2015 | -0.3026 |
| March 31, 2015 | -0.275 |
| December 31, 2014 | -0.3019 |
| September 30, 2014 | -0.2766 |
| June 30, 2014 | -0.2794 |
| March 31, 2014 | -0.2178 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| Accuray, Inc. | 4.502 |
| Micron Solutions, Inc. | -- |
| Perspective Therapeutics, Inc. | 0.0122 |
| Orthofix Medical, Inc. | 0.6102 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0448M |
| Total Liabilities (Quarterly) | 30.09M |
| Shareholders Equity (Quarterly) | -30.05M |
| Current Ratio | 0.0014 |
| Net Debt Paydown Yield | -1.87K% |